Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Anti-tumor necrosis factor-alpha therapy improves endothelial function and arterial stiffness in patients with moderate to severe psoriasis: A 6-month prospective study.
Pina T, Corrales A, Lopez-Mejias R, Armesto S, Gonzalez-Lopez MA, Gómez-Acebo I, Ubilla B, Remuzgo-Martínez S, Gonzalez-Vela MC, Blanco R, Hernández JL, Llorca J, Gonzalez-Gay MA. Pina T, et al. Among authors: ubilla b. J Dermatol. 2016 Nov;43(11):1267-1272. doi: 10.1111/1346-8138.13398. Epub 2016 Apr 7. J Dermatol. 2016. PMID: 27062420 Clinical Trial.
Patients with ankylosing spondylitis and low disease activity because of anti-TNF-alpha therapy have higher TRAIL levels than controls: a potential compensatory effect.
Genre F, López-Mejías R, Rueda-Gotor J, Miranda-Filloy JA, Ubilla B, Carnero-López B, Palmou-Fontana N, Gómez-Acebo I, Blanco R, Pina T, Ochoa R, González-Juanatey C, Llorca J, González-Gay MA. Genre F, et al. Among authors: ubilla b. Mediators Inflamm. 2014;2014:798060. doi: 10.1155/2014/798060. Epub 2014 May 21. Mediators Inflamm. 2014. PMID: 24976690 Free PMC article.
Osteoprotegerin correlates with disease activity and endothelial activation in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy.
Genre F, López-Mejías R, Miranda-Filloy JA, Ubilla B, Carnero-López B, Palmou-Fontana N, Gómez-Acebo I, Blanco R, Rueda-Gotor J, Pina T, González-Juanatey C, Llorca J, González-Gay MÁ. Genre F, et al. Among authors: ubilla b. Clin Exp Rheumatol. 2014 Sep-Oct;32(5):640-6. Epub 2014 Sep 5. Clin Exp Rheumatol. 2014. PMID: 25190453
Anti-TNF-α therapy reduces endothelial cell activation in non-diabetic ankylosing spondylitis patients.
Genre F, López-Mejías R, Miranda-Filloy JA, Ubilla B, Mijares V, Carnero-López B, Gómez-Acebo I, Dierssen-Sotos T, Remuzgo-Martínez S, Blanco R, Pina T, González-Juanatey C, Llorca J, González-Gay MA. Genre F, et al. Among authors: ubilla b. Rheumatol Int. 2015 Dec;35(12):2069-78. doi: 10.1007/s00296-015-3314-1. Epub 2015 Jul 5. Rheumatol Int. 2015. PMID: 26143161
Asymmetric dimethylarginine but not osteoprotegerin correlates with disease severity in patients with moderate-to-severe psoriasis undergoing anti-tumor necrosis factor-α therapy.
Pina T, Genre F, Lopez-Mejias R, Armesto S, Ubilla B, Mijares V, Dierssen-Sotos T, Corrales A, Gonzalez-Lopez MA, Gonzalez-Vela MC, Blanco R, Hernández JL, Llorca J, Gonzalez-Gay MA. Pina T, et al. Among authors: ubilla b. J Dermatol. 2016 Apr;43(4):389-94. doi: 10.1111/1346-8138.13094. Epub 2015 Sep 14. J Dermatol. 2016. PMID: 26364678
Significant sE-Selectin levels reduction after 6 months of anti-TNF-α therapy in non-diabetic patients with moderate-to-severe psoriasis.
Genre F, Armesto S, Corrales A, López-Mejías R, Remuzgo-Martínez S, Pina T, Ubilla B, Mijares V, Martín-Varillas JL, Rueda-Gotor J, Portilla V, Dierssen-Sotos T, González-López MA, González-Vela MDC, Blanco R, Llorca J, Hernández JL, González-Gay MÁ. Genre F, et al. Among authors: ubilla b. J Dermatolog Treat. 2017 Dec;28(8):726-730. doi: 10.1080/09546634.2017.1329498. Epub 2017 May 31. J Dermatolog Treat. 2017. PMID: 28489469 Free article.
Anti-TNF-α therapy improves insulin sensitivity in non-diabetic patients with psoriasis: a 6-month prospective study.
Pina T, Armesto S, Lopez-Mejias R, Genre F, Ubilla B, Gonzalez-Lopez MA, Gonzalez-Vela MC, Corrales A, Blanco R, Garcia-Unzueta MT, Hernandez JL, Llorca J, Gonzalez-Gay MA. Pina T, et al. Among authors: ubilla b. J Eur Acad Dermatol Venereol. 2015 Jul;29(7):1325-30. doi: 10.1111/jdv.12814. Epub 2014 Oct 29. J Eur Acad Dermatol Venereol. 2015. PMID: 25353352
Anti-TNF-α therapy reduces retinol-binding protein 4 serum levels in non-diabetic patients with psoriasis: a 6-month prospective study.
Pina T, Genre F, Lopez-Mejias R, Armesto S, Ubilla B, Mijares V, Dierssen-Sotos T, Corrales A, Gonzalez-Lopez MA, Gonzalez-Vela MC, Blanco R, Llorca J, Gonzalez-Gay MA. Pina T, et al. Among authors: ubilla b. J Eur Acad Dermatol Venereol. 2016 Jan;30(1):92-5. doi: 10.1111/jdv.13005. Epub 2015 Feb 4. J Eur Acad Dermatol Venereol. 2016. PMID: 25650695
42 results